BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

AviGenics, Inc

AviGenics is a biotechnology company developing therapeutic proteins for oncology, infectious diseases and autoimmune diseases. By employing its proprietary technology, AviGenics has successfully produced six bioactive therapeutic proteins, including improved versions of three currently marketed products which compete in established markets with annual sales of $12 billion.
AviGenics’ proprietary technology produces therapeutic proteins with human-like glycosylation, leading to well tolerated products with increased half-life and enhanced clinical efficacy. Using this technology, the Company has demonstrated that it can achieve commercially feasible levels of production and purification for therapeutic proteins. In comparison with the traditional production methods, the Company’s technology offers rapid and efficient product development, a clear and well established regulatory process for product approval, and a substantial reduction in capital expenditures (up to 90%) and drug manufacturing costs (up to 75%).


Contact Details:
111 Riverbend Road
Athens
Georgia
30602
United States of America
Tel:706-227-1170
Fax:706-227-2180
Email:information@avigenics.com
WWW:

www.avigenics.com/




Loading...

BioNews Results for AviGenics, Inc:

Experts talk about biotech industry's future in Athens area
OnlineAthens:  Sep 15 2008 3:15AM Matching: avigenics inc
BioPartnering Europe 2008 Conference: Technology Vision Group Presents Extensive Conference Programme
Pharma Live:  Sep 11 2008 7:25PM Matching: avigenics inc
Company and People Notes: FTC Asks Teva and Barr For Additional Information, GSK's Chris Viehbacher to Leave C
Pharmaceutical Technology:  Sep 10 2008 9:27PM Matching: avigenics inc
BioPartnering Europe 2008 Conference: Technology Vision Group Presents Extensive Conference Programme
Business Wire via Yahoo!:  Sep 9 2008 5:30PM Matching: avigenics inc

AviGenics, Inc Patents:

US Patent No.Title
7381712 In vivo transfection in avians
6730822 Vectors in avian transgenesis
6875588 Ovomucoid promoter and methods of use
7049480 Methods of enucleating an avian oocyte or zygote using two-photon laser scanning microscopy
7122309 High throughput screening assay for detecting a DNA sequence

View more AviGenics, Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 368 times since April 2007, the link to the organisation's website has been followed 59 times

Recent Search Terms used to find this page: Avigenics Inc | Avigenics Inc. | avigenics inc | avigenics inc | information avigenics.com | aviGenics | Avigenics Patent | avigenics inc | avigenics | capital expenditures avigenics | .

Search for more companies in Athens

Search for more companies in Georgia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AviGenics, Inc
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.